Cargando…

Case Report: Mutant SCN9A Susceptible to Charcot Neuroarthropathy in a Patient With Congenital Insensitivity to Pain

Charcot neuroarthropathy is a systemic disease with pathological changes in the musculoskeletal system, which leads to fractures, dislocations, and deformities involving multiple bones and joints, particularly those of the feet. While the common underlying cause of Charcot neuroarthropathy is diabet...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Xiao-hui, Tang, Jian-guang, Liu, Zhong-hua, Peng, Shui-jiao, Yuan, Zhuang-zhuang, Gu, Heng, Hu, Yi-qiao, Tan, Zhi-ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317969/
https://www.ncbi.nlm.nih.gov/pubmed/34335171
http://dx.doi.org/10.3389/fnins.2021.697167
_version_ 1783730158053621760
author Xie, Xiao-hui
Tang, Jian-guang
Liu, Zhong-hua
Peng, Shui-jiao
Yuan, Zhuang-zhuang
Gu, Heng
Hu, Yi-qiao
Tan, Zhi-ping
author_facet Xie, Xiao-hui
Tang, Jian-guang
Liu, Zhong-hua
Peng, Shui-jiao
Yuan, Zhuang-zhuang
Gu, Heng
Hu, Yi-qiao
Tan, Zhi-ping
author_sort Xie, Xiao-hui
collection PubMed
description Charcot neuroarthropathy is a systemic disease with pathological changes in the musculoskeletal system, which leads to fractures, dislocations, and deformities involving multiple bones and joints, particularly those of the feet. While the common underlying cause of Charcot neuroarthropathy is diabetes mellitus, it is also associated with congenital insensitivity to pain (CIP). CIP is a rare disorder caused by loss-of-function mutations in SCN9A encoding Nav1.7. In this study, we report a patient with CIP from a consanguineous family susceptible to Charcot neuroarthropathy with a novel SCN9A mutation. This report involves the case of a middle-aged man who suffered from CIP, had repeated painless fractures, and developed bone and joint destruction. The physical and radiological examinations revealed that multiple joints were swollen and deformed, and soft-tissue trauma was evident. We identified a novel homozygous SCN9A mutation (p.Cys1339Arg) by whole-exome sequencing (WES), which was verified using Sanger sequencing. In addition, the wild-type (WT) and mutated p. Cys1339Arg were assessed in HEK293 cells expressing Nav1.7, and the results showed that p. Cys1339Arg almost abolished the Nav1.7 sodium current. In conclusion, Charcot neuroarthropathy associated with CIP demonstrated a wider spectrum of Charcot neuroarthropathy than was previously recognized or documented. In addition, this finding is conducive to understanding the critical amino acids for maintaining the function of Nav1.7, thus contributing to the development of Nav1.7-targeted analgesics.
format Online
Article
Text
id pubmed-8317969
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-83179692021-07-29 Case Report: Mutant SCN9A Susceptible to Charcot Neuroarthropathy in a Patient With Congenital Insensitivity to Pain Xie, Xiao-hui Tang, Jian-guang Liu, Zhong-hua Peng, Shui-jiao Yuan, Zhuang-zhuang Gu, Heng Hu, Yi-qiao Tan, Zhi-ping Front Neurosci Neuroscience Charcot neuroarthropathy is a systemic disease with pathological changes in the musculoskeletal system, which leads to fractures, dislocations, and deformities involving multiple bones and joints, particularly those of the feet. While the common underlying cause of Charcot neuroarthropathy is diabetes mellitus, it is also associated with congenital insensitivity to pain (CIP). CIP is a rare disorder caused by loss-of-function mutations in SCN9A encoding Nav1.7. In this study, we report a patient with CIP from a consanguineous family susceptible to Charcot neuroarthropathy with a novel SCN9A mutation. This report involves the case of a middle-aged man who suffered from CIP, had repeated painless fractures, and developed bone and joint destruction. The physical and radiological examinations revealed that multiple joints were swollen and deformed, and soft-tissue trauma was evident. We identified a novel homozygous SCN9A mutation (p.Cys1339Arg) by whole-exome sequencing (WES), which was verified using Sanger sequencing. In addition, the wild-type (WT) and mutated p. Cys1339Arg were assessed in HEK293 cells expressing Nav1.7, and the results showed that p. Cys1339Arg almost abolished the Nav1.7 sodium current. In conclusion, Charcot neuroarthropathy associated with CIP demonstrated a wider spectrum of Charcot neuroarthropathy than was previously recognized or documented. In addition, this finding is conducive to understanding the critical amino acids for maintaining the function of Nav1.7, thus contributing to the development of Nav1.7-targeted analgesics. Frontiers Media S.A. 2021-07-14 /pmc/articles/PMC8317969/ /pubmed/34335171 http://dx.doi.org/10.3389/fnins.2021.697167 Text en Copyright © 2021 Xie, Tang, Liu, Peng, Yuan, Gu, Hu and Tan. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Xie, Xiao-hui
Tang, Jian-guang
Liu, Zhong-hua
Peng, Shui-jiao
Yuan, Zhuang-zhuang
Gu, Heng
Hu, Yi-qiao
Tan, Zhi-ping
Case Report: Mutant SCN9A Susceptible to Charcot Neuroarthropathy in a Patient With Congenital Insensitivity to Pain
title Case Report: Mutant SCN9A Susceptible to Charcot Neuroarthropathy in a Patient With Congenital Insensitivity to Pain
title_full Case Report: Mutant SCN9A Susceptible to Charcot Neuroarthropathy in a Patient With Congenital Insensitivity to Pain
title_fullStr Case Report: Mutant SCN9A Susceptible to Charcot Neuroarthropathy in a Patient With Congenital Insensitivity to Pain
title_full_unstemmed Case Report: Mutant SCN9A Susceptible to Charcot Neuroarthropathy in a Patient With Congenital Insensitivity to Pain
title_short Case Report: Mutant SCN9A Susceptible to Charcot Neuroarthropathy in a Patient With Congenital Insensitivity to Pain
title_sort case report: mutant scn9a susceptible to charcot neuroarthropathy in a patient with congenital insensitivity to pain
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8317969/
https://www.ncbi.nlm.nih.gov/pubmed/34335171
http://dx.doi.org/10.3389/fnins.2021.697167
work_keys_str_mv AT xiexiaohui casereportmutantscn9asusceptibletocharcotneuroarthropathyinapatientwithcongenitalinsensitivitytopain
AT tangjianguang casereportmutantscn9asusceptibletocharcotneuroarthropathyinapatientwithcongenitalinsensitivitytopain
AT liuzhonghua casereportmutantscn9asusceptibletocharcotneuroarthropathyinapatientwithcongenitalinsensitivitytopain
AT pengshuijiao casereportmutantscn9asusceptibletocharcotneuroarthropathyinapatientwithcongenitalinsensitivitytopain
AT yuanzhuangzhuang casereportmutantscn9asusceptibletocharcotneuroarthropathyinapatientwithcongenitalinsensitivitytopain
AT guheng casereportmutantscn9asusceptibletocharcotneuroarthropathyinapatientwithcongenitalinsensitivitytopain
AT huyiqiao casereportmutantscn9asusceptibletocharcotneuroarthropathyinapatientwithcongenitalinsensitivitytopain
AT tanzhiping casereportmutantscn9asusceptibletocharcotneuroarthropathyinapatientwithcongenitalinsensitivitytopain